Multi-drug Resistant Bacteria

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Multi-drug Resistant Bacteria trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

RecruitingPhase 1/2

NCT04759001

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Rates of antimicrobial resistance are increasing worldwide. There is increasing evidence that physiological gut microbiota is a large reservoir of antibiotic-re…

Italy52 participantsStarted 2021-02-18

Treatment: Donor FMT, Placebo FMT

RecruitingPhase 1/2

NCT05791396

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Antibiotic resistance (AR) is a critical public health threat and one of the greatest challenges of the 21st century. In an estimate of 2019, nearly 700.000 inf…

Italy36 participantsStarted 2024-02-08

Treatment: Donor - FMT, Placebo FMT

RecruitingNot Applicable

NCT06782880

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

The increasing emergence and spread of MDRB represents a major public health problem, with higher mortality in patients experiencing infections. Cirrhotic patie…

Italy144 participantsStarted 2023-05-01

Treatment: Fecal microbiota transplantation (FMT)

RecruitingNot Applicable

NCT06148480

Perinatal Transmission of MDR Bacteria

The investigators aim to conduct a prospective surveillance study of mothers and their infants born vaginally or by scheduled C-section and who are admitted to…

United States200 participantsStarted 2020-07-17

RecruitingPhase 2/3

NCT04188743

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

Colonization by Multiple Drug Resistant Organisms (MDROs) during patient hospitalization requires expensive isolation measures and renders the return or transfe…

Belgium150 participantsStarted 2019-12-18

Treatment: Allogenic FMT, Autologous FMT

All recent trials (29 shown)

Not Yet RecruitingPhase 2

NCT07524920

Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Mul…

This study aims to compare the efficacy and safety of two antibiotic combinations (Colistin + Meropenem) vs (Imipenem/cilastatin+ Tigecycline) in the treatment…

Egypt60 participantsStarted 2026-04-01

Treatment: "Imipenem/cilastatin" and "Tigecycline", "colistin" and "meropenem"

Not Yet RecruitingNot Applicable

NCT07505446

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Multidrug-resistant (MDR) bacteria represent a significant global health challenge, particularly among immunocompromised populations such as cancer patients und…

Location not specified100 participantsStarted 2026-05-01

Treatment: verapamil

Multi-drug Resistant Bacteria

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

Perinatal Transmission of MDR Bacteria

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

All recent trials (29 shown)

Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Mul…

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

Perinatal Transmission of MDR Bacteria

Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)

All recent trials (29 shown)

Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Mul…

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Phenotypic and Genotypic Detection of Colistin Resistance

Prevalence of Multi-Drug Resistant Bacteria in Long-term Care Facilities

Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline

A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus…

Testing Carriage of Resistant Bacteria Using Swabs on Surfaces and Staff in a Complex Nursing Unit for Patients with Res…

Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative B…

Risk Factors for Multidrug Resistant Bacteria at ICU Admission

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

M-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia

Enhanced Room Cleaning in Intensive Care Units to Reduce Gown and Glove Contamination With Multi-drug-resistant Bacteria

Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria

Nosocomial Bacteriuria in Geriatric Internal Medicine Services and Follow-up Care and Geriatric Rehabilitation of the St…

Multi-Drug Resistant Bacteria Carriage After Travel

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread

Standard Precautions Versus Contact Additional Precautions Against Multi-drug Resistant Bacteria in Intensive Care Unit…